Title |
Pharmacological management of binge eating disorder: current and emerging treatment options
|
---|---|
Published in |
Therapeutics and Clinical Risk Management, May 2012
|
DOI | 10.2147/tcrm.s25574 |
Pubmed ID | |
Authors |
Susan L McElroy, Anna I Guerdjikova, Nicole Mori, Anne M O’Melia |
Abstract |
Growing evidence suggests that pharmacotherapy may be beneficial for some patients with binge eating disorder (BED), an eating disorder characterized by repetitive episodes of uncontrollable consumption of abnormally large amounts of food without inappropriate weight loss behaviors. In this paper, we provide a brief overview of BED and review the rationales and data supporting the effectiveness of specific medications or medication classes in treating patients with BED. We conclude by summarizing these data, discussing the role of pharmacotherapy in the BED treatment armamentarium, and suggesting future areas for research. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 22% |
Australia | 2 | 22% |
United Kingdom | 1 | 11% |
Unknown | 4 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 44% |
Scientists | 2 | 22% |
Practitioners (doctors, other healthcare professionals) | 2 | 22% |
Science communicators (journalists, bloggers, editors) | 1 | 11% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 3 | 2% |
United States | 1 | <1% |
Germany | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 191 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 30 | 15% |
Researcher | 29 | 15% |
Student > Bachelor | 29 | 15% |
Student > Ph. D. Student | 20 | 10% |
Student > Doctoral Student | 12 | 6% |
Other | 35 | 18% |
Unknown | 42 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 48 | 24% |
Psychology | 42 | 21% |
Agricultural and Biological Sciences | 18 | 9% |
Neuroscience | 11 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 4% |
Other | 26 | 13% |
Unknown | 44 | 22% |